Bi Jiacheng相关文献与解析，生知库 | 链接生命科学的每一步

Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma.

靶向抑制 Nrf2 可增强抗肿瘤免疫力，提高肝细胞癌免疫疗法的疗效。

doi:10.1136/jitc-2024-010841

Zhu Yan, Liu Maoxuan, Fan Xiaokai, Xu Yingying, Diao Xueling, Bi Jiacheng, Wan Xiaochun, Assaraf Yehuda G, Kwok Hang Fai, Chen Liang

Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinoma.

中心体蛋白 TAX1BP2 介导 STING 依赖性免疫反应，并增强抗 PD-1 在肝细胞癌中的疗效

期刊:Molecular Therapy

影响因子:12

doi:10.1016/j.ymthe.2025.01.043

Zhang Qingmei, Chan Wing-Lim, Fung Sin-Yee, Pang Li, Ding Tao, Teo Jia Ming Nickolas, Zhou Yuan, Wu Chung Ming Alex, Siu Kam-Leung, Bi Jiacheng, Ling Guang Sheng, Jin Dong-Yan, Man Kwan, Ching Yick Pang

Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8(+) T Cells

检查点TIPE2限制NK细胞辅助抗肿瘤CD8(+) T细胞的功能

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202207499

Bi, Jiacheng; Jin, Xiaomeng; Zheng, Chaoyue; Huang, Chen; Zhong, Chao; Zheng, Xiaohu; Tian, Zhigang; Sun, Haoyu

Review immune response of targeting CD39 in cancer

探讨靶向CD39的癌症免疫反应

期刊:Biomarker Research

影响因子:11.5

doi:10.1186/s40364-023-00500-w

Liu, Yao; Li, Zhongliang; Zhao, Xiaoguang; Xiao, Jing; Bi, Jiacheng; Li, Xian-Yang; Chen, Guokai; Lu, Ligong

NK cell dysfunction in patients with COVID-19

新冠肺炎患者的NK细胞功能障碍

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-021-00825-2

CD226: a potent driver of antitumor immunity that needs to be maintained

CD226：一种强效的抗肿瘤免疫驱动因子，需要维持其活性。

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-020-00633-0

The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy

免疫疗法中超细胞因子、免疫细胞因子、衔接细胞因子和其他合成细胞因子的应用

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-021-00786-6

Zheng, Xiaohu; Wu, Yaqi; Bi, Jiacheng; Huang, Yingying; Cheng, Ying; Li, Yangyang; Wu, Yuwei; Cao, Guoshuai; Tian, Zhigang

Prospects for NK-based immunotherapy of chronic HBV infection

NK细胞免疫疗法治疗慢性乙型肝炎病毒感染的前景

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2022.1084109

Jin, Xiaomeng; Bi, Jiacheng

Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells

肿瘤浸润性自然杀伤细胞中腺苷A3受体表达增加

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/s41423-020-00632-1

Bi, Jiacheng; Zheng, Chaoyue; Zheng, Xiaohu

TRIM11 potentiates antitumor immunity via inhibition of the IFN-Î³/PD-L1 axis.

TRIM11 通过抑制 IFN-γ/PD-L1 轴增强抗肿瘤免疫力。

Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma.

靶向抑制 Nrf2 可增强抗肿瘤免疫力，提高肝细胞癌免疫疗法的疗效。

Centrosome protein TAX1BP2 mediates STING-dependent immune response and potentiates anti-PD-1 efficacy in hepatocellular carcinoma.

中心体蛋白 TAX1BP2 介导 STING 依赖性免疫反应，并增强抗 PD-1 在肝细胞癌中的疗效

Checkpoint TIPE2 Limits the Helper Functions of NK Cells in Supporting Antitumor CD8(+) T Cells

检查点TIPE2限制NK细胞辅助抗肿瘤CD8(+) T细胞的功能

Review immune response of targeting CD39 in cancer

探讨靶向CD39的癌症免疫反应

NK cell dysfunction in patients with COVID-19

新冠肺炎患者的NK细胞功能障碍

CD226: a potent driver of antitumor immunity that needs to be maintained

CD226：一种强效的抗肿瘤免疫驱动因子，需要维持其活性。

The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy

免疫疗法中超细胞因子、免疫细胞因子、衔接细胞因子和其他合成细胞因子的应用

Prospects for NK-based immunotherapy of chronic HBV infection

NK细胞免疫疗法治疗慢性乙型肝炎病毒感染的前景

Increased expression of adenosine A3 receptor in tumor-infiltrating natural killer cells

肿瘤浸润性自然杀伤细胞中腺苷A3受体表达增加